Lexeo Therapeutics, Inc. (LXEO)

NASDAQ: LXEO · IEX Real-Time Price · USD

14.02

-1.59 (-10.19%)

At close: Jul 2, 2024, 4:00 PM

14.72

+0.70 (4.99%)

After-hours: Jul 2, 2024, 7:19 PM EDT

Lexeo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	124.72	80.59	135.86
Cash & Cash Equivalents	124.72	80.59	135.86
Cash Growth	54.76%	-40.68%	-
Other Current Assets	-0.42	-0.54	0.82
Total Current Assets	124.29	80.05	136.68
Property, Plant & Equipment	12.26	13.78	0.17
Other Long-Term Assets	3.25	3.25	0
Total Long-Term Assets	15.51	17.03	0.18
Total Assets	139.81	97.08	136.86
Accounts Payable	3.79	2.68	3.06
Deferred Revenue	0	0	0.05
Current Debt	2.61	2.83	0
Other Current Liabilities	10.84	8.84	4.34
Total Current Liabilities	17.24	14.35	7.45
Long-Term Debt	9.03	10.65	0
Total Long-Term Liabilities	9.03	10.65	0
Total Liabilities	26.27	25	7.45
Total Debt	11.64	13.48	0
Debt Growth	-13.68%	-	-
Retained Earnings	-181.84	-115.45	-56.17
Shareholders' Equity	113.54	-112.95	-55.6
Net Cash / Debt	113.08	67.11	135.86
Net Cash / Debt Growth	68.51%	-50.61%	-
Net Cash Per Share	21.12	41.16	87.50
Working Capital	107.06	65.7	129.24
Book Value Per Share	21.20	-69.28	-35.81

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).